Literature DB >> 16849469

Crucial commitment of proteolytic activity of a purified recombinant major house dust mite allergen Der p1 to sensitization toward IgE and IgG responses.

Yuko Kikuchi1, Toshiro Takai, Takatoshi Kuhara, Mikiko Ota, Takeshi Kato, Hideki Hatanaka, Saori Ichikawa, Tomoko Tokura, Hisaya Akiba, Kouichi Mitsuishi, Shigaku Ikeda, Ko Okumura, Hideoki Ogawa.   

Abstract

The major proteolytic allergen derived from the house dust mite Dermatophagoides pteronyssinus, Der p1, is one of the most clinically relevant allergens worldwide. In the present study, we evaluate the contribution of the proteolytic activity and structure of a highly purified rDer p 1 to immune responses. Mice were i.p. immunized with three forms of rDer p 1 adsorbed to Alum: one enzymatically active, one treated with an irreversible cysteine protease-specific inhibitor, E-64, and one heat denatured. Immunization with E-64-treated or heat-denatured rDer p 1 elicited much less production of serum total IgE and not only rDer p 1-specific IgE but also IgGs compared with immunization with active rDer p 1. Assays for Ab-binding and its inhibition and structural analyses indicated that E-64-treated rDer p 1 retained its global structure and conformational B cell epitopes. A proliferative response and production of IL-5 by spleen cells restimulated with rDer p 1 were observed on immunization with the active rDer p 1 but not E-64-treated rDer p 1. The cells from mice immunized with heat-denatured rDer p 1 exhibited the highest levels of proliferation and production of IL-5 and IFN-gamma. The results indicate that the proteolytic activity of the highly purified rDer p 1 crucially commits to the sensitization process, including both IgE and IgG responses. Additionally, we demonstrated immunogenic differences by functional or structural manipulations of the rDer p 1. The findings have implications for sensitization to this relevant allergen in humans and for the design of modified allergen-vaccines for future allergen-specific immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849469     DOI: 10.4049/jimmunol.177.3.1609

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Dangerous allergens: why some allergens are bad actors.

Authors:  Steve N Georas; Fariba Rezaee; Laurie Lerner; Lisa Beck
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

Review 2.  Allergen structures and biologic functions: the cutting edge of allergy research.

Authors:  Anna Pomés
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

Review 3.  Cytokine profiles in allergic rhinitis.

Authors:  Guy Scadding
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

4.  CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity.

Authors:  Yosuke Kumamoto; Melissa Linehan; Jason S Weinstein; Brian J Laidlaw; Joseph E Craft; Akiko Iwasaki
Journal:  Immunity       Date:  2013-09-26       Impact factor: 31.745

Review 5.  Sensory neurons control the functions of dendritic cells to guide allergic immunity.

Authors:  Cameron H Flayer; Caroline L Sokol
Journal:  Curr Opin Immunol       Date:  2021-11-19       Impact factor: 7.486

Review 6.  T and B cell responses to HDM allergens and antigens.

Authors:  Wayne R Thomas; Belinda J Hales
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  A synthetic Toll-like receptor 2 ligand decreases allergic immune responses in a mouse rhinitis model sensitized to mite allergen.

Authors:  Cheng Zhou; Xiao-Dong Kang; Zhi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

8.  Effect of proteolytic activity of Epicoccum purpurascens major allergen, Epi p 1 in allergic inflammation.

Authors:  N Kukreja; S Sridhara; B P Singh; N Arora
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

Review 9.  Proteases as Th2 adjuvants.

Authors:  Martin D Chapman; Sabina Wünschmann; Anna Pomés
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

10.  Inactivation of common airborne antigens by perfluoroalkyl chemicals modulates early life allergic asthma.

Authors:  Mengjing Wang; Qianqian Li; Meifang Hou; Louisa L Y Chan; Meng Liu; Soo Kai Ter; Ting Dong; Yun Xia; Sanjay H Chotirmall; Mingliang Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.